Vivos Inc (RDGL)

$0.07 +0.00 (2.00%)
Market Cap 32.09M
Revenue (ttm) 70,000.00
Net Income (ttm) -3.07M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,385.71%
Debt to Equity Ratio 0.00
Volume 419,000
Avg Vol 1,549,914
Day's Range N/A - N/A
Shares Out 493.74M
Stochastic %K 69%
Beta -0.76
Analysts Strong Buy
Price Target N/A

Company Profile

Vivos Inc., a radiation oncology medical device company, engages in the development of yttrium-90-based precision radionuclide therapy devices for the treatment of non-resectable tumors in the United States. The company develops RadioGel, which is an injectable particle-gel for Precision Radionuclide Therapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. It is also developing PLGA-g-PEG polymers; PrecisionGel, a hydrogel po...

Industry: Medical Devices
Sector: Healthcare
Phone: 509 222 2222
Address:
1030 N Center Parkway, Suite N288, Kennewick, United States
bud63
bud63 Jun. 13 at 5:55 PM
$RDGL As of May 2026 “approximately 60 efs IDEs have been approved per year since 2017.There has been >4000 EFS participants since these studies have been tracked .” *Dorothy Abel ,Aditi Upadhye RAC
0 · Reply
Den44
Den44 Jun. 12 at 3:42 PM
$RDGL VIivos inc. submits Early Feasibility Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) for RadioGel® Precision Radionuclide Therapy™ 🚀 $SPCX https://www.biospace.com/press-releases/vivos-inc-otcqb-rdgl-submits-early-feasibility-investigational-device-exemption-ide-application-to-the-u-s-food-and-drug-administration-fda-for-radiogel-precision-radionuclide-therapy
1 · Reply
Doccjc62
Doccjc62 Jun. 12 at 1:59 PM
$RDGL Bid moving up..
2 · Reply
Phil1981
Phil1981 Jun. 11 at 1:46 PM
$RDGL SP not fucking budging until we get acceptance! We got this though
2 · Reply
Daybyday5
Daybyday5 Jun. 11 at 12:54 PM
$RDGL https://www.globenewswire.com/news-release/2026/06/11/3310458/0/en/vivos-inc-announces-receipt-of-washington-state-radioactive-materials-license-for-isopet-manufacturing.html
0 · Reply
anderson800
anderson800 Jun. 11 at 12:51 PM
$RDGL Getting the license is great news. I've been waiting 6 months for action by our state on a license renewal so most people won't see this as a big deal, but this is a very large step on the regulatory side. And I think this shows also that they are definitely planning for the future like they will get FDA approval.
2 · Reply
Doccjc62
Doccjc62 Jun. 11 at 12:41 PM
$RDGL https://x.com/vivosincusa/status/2065050253129331078?s=46&t=vL-KXYXZYnhJDJaIoa-ARw
0 · Reply
UWB67
UWB67 Jun. 11 at 12:37 PM
$RDGL https://www.otcmarkets.com/stock/RDGL/news/Vivos-Inc-Announces-Receipt-of-Washington-State-Radioactive-Materials-License-for-IsoPet-Manufacturing?id=524724 $1+. Organically. GO VIVOS GO!! 🤞👏🙌🐂
0 · Reply
UWB67
UWB67 Jun. 11 at 12:34 PM
$RDGL Vivos Inc. Announces Receipt of Washington State Radioactive Materials License for IsoPet® Manufacturing 6/11/2026 8:30am Kennewick, WA, June 11, 2026 (GLOBE NEWSWIRE) --Vivos Inc. (OTCQB: RDGL), a medical device company pioneering Precision Radionuclide Therapy™ (PRnT) for the treatment of cancerous tumors, is pleased to announce that it has received its State of Washington Radioactive Materials License for the manufacturing of IsoPet® This approval represents a significant regulatory milestone for the Company's animal health division. It clears the way for in-house production of IsoPet® at Vivos' new domestic manufacturing facility located at the Applied Process Engineering Laboratory (APEL) in Richland, Washington. $1+. Organically. GO VIVOS GO!! 🤞👏🙌🐂
0 · Reply
Richbagholderr
Richbagholderr Jun. 9 at 1:45 PM
$RDGL a reminder
0 · Reply
Latest News on RDGL
No data available.
bud63
bud63 Jun. 13 at 5:55 PM
$RDGL As of May 2026 “approximately 60 efs IDEs have been approved per year since 2017.There has been >4000 EFS participants since these studies have been tracked .” *Dorothy Abel ,Aditi Upadhye RAC
0 · Reply
Den44
Den44 Jun. 12 at 3:42 PM
$RDGL VIivos inc. submits Early Feasibility Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) for RadioGel® Precision Radionuclide Therapy™ 🚀 $SPCX https://www.biospace.com/press-releases/vivos-inc-otcqb-rdgl-submits-early-feasibility-investigational-device-exemption-ide-application-to-the-u-s-food-and-drug-administration-fda-for-radiogel-precision-radionuclide-therapy
1 · Reply
Doccjc62
Doccjc62 Jun. 12 at 1:59 PM
$RDGL Bid moving up..
2 · Reply
Phil1981
Phil1981 Jun. 11 at 1:46 PM
$RDGL SP not fucking budging until we get acceptance! We got this though
2 · Reply
Daybyday5
Daybyday5 Jun. 11 at 12:54 PM
$RDGL https://www.globenewswire.com/news-release/2026/06/11/3310458/0/en/vivos-inc-announces-receipt-of-washington-state-radioactive-materials-license-for-isopet-manufacturing.html
0 · Reply
anderson800
anderson800 Jun. 11 at 12:51 PM
$RDGL Getting the license is great news. I've been waiting 6 months for action by our state on a license renewal so most people won't see this as a big deal, but this is a very large step on the regulatory side. And I think this shows also that they are definitely planning for the future like they will get FDA approval.
2 · Reply
Doccjc62
Doccjc62 Jun. 11 at 12:41 PM
$RDGL https://x.com/vivosincusa/status/2065050253129331078?s=46&t=vL-KXYXZYnhJDJaIoa-ARw
0 · Reply
UWB67
UWB67 Jun. 11 at 12:37 PM
$RDGL https://www.otcmarkets.com/stock/RDGL/news/Vivos-Inc-Announces-Receipt-of-Washington-State-Radioactive-Materials-License-for-IsoPet-Manufacturing?id=524724 $1+. Organically. GO VIVOS GO!! 🤞👏🙌🐂
0 · Reply
UWB67
UWB67 Jun. 11 at 12:34 PM
$RDGL Vivos Inc. Announces Receipt of Washington State Radioactive Materials License for IsoPet® Manufacturing 6/11/2026 8:30am Kennewick, WA, June 11, 2026 (GLOBE NEWSWIRE) --Vivos Inc. (OTCQB: RDGL), a medical device company pioneering Precision Radionuclide Therapy™ (PRnT) for the treatment of cancerous tumors, is pleased to announce that it has received its State of Washington Radioactive Materials License for the manufacturing of IsoPet® This approval represents a significant regulatory milestone for the Company's animal health division. It clears the way for in-house production of IsoPet® at Vivos' new domestic manufacturing facility located at the Applied Process Engineering Laboratory (APEL) in Richland, Washington. $1+. Organically. GO VIVOS GO!! 🤞👏🙌🐂
0 · Reply
Richbagholderr
Richbagholderr Jun. 9 at 1:45 PM
$RDGL a reminder
0 · Reply
UWB67
UWB67 Jun. 9 at 9:30 AM
$RDGL Naysayers aka DUMMIES are LIARS and ILLITERATE TRYING to take away from the Vivos EFS IDE submission on 5 June 2026 by stating (lying) that Vivos chose another path by submitting an EFS IDE. Do your due dilligence: Vivos Inc. Files Early Feasibility IDE Application with FDA for Radiogel™GlobeNewswire | 09/20/2021: https://www.otcmarkets.com/stock/RDGL/news/Vivos-Inc-Files-Early-Feasibility-IDE-Application-with-FDA-for-Radiogel?id=321527 Vivos' goal was ALWAYS to submit an EFS IDE to the FDA to begin human trials in the US. Lying illiterate dummies. EFS IDE APPROVAL will be a HUGE milestone for Vivos. DCGI (India) APPROVAL to conduct tests in humans towards commercialization in India will be a HUGE milestone for Vivos. $1+. Organically. GO VIVOS GO!! 🤞👏🙌👏🤞🐂
0 · Reply
Rogggggg
Rogggggg Jun. 9 at 3:54 AM
$RDGL
0 · Reply
Rogggggg
Rogggggg Jun. 9 at 3:37 AM
$RDGL if not approved this time, does the company continue operating? How many more times can they continue?
1 · Reply
Dumbdumb4ever
Dumbdumb4ever Jun. 8 at 3:32 PM
$RDGL Everyone seems to forget the importance of the India angle. If we get the EFS approved, and we move on to the next stage in India, you unlock the results there that can be brought into the US. Significantly expediting the US pathway. Since you’re already doing EFS, with much closer collaboration with the FDA, communicating these results expedites the overall application. We’re 2-3 years away from US commercialization and 1.5 to 2 in India. If we aren’t bought out before. And we’re not even discussing another angle most likely in other regions if we can sign agreements.
1 · Reply
WhatTheFinger
WhatTheFinger Jun. 8 at 2:06 PM
$RDGL fking better be approved this time. The price has taken enough hits already and the price responded virtually not at all to this submission news.
3 · Reply
UWB67
UWB67 Jun. 6 at 3:28 PM
$RDGL $1+. Organically. GO VIVOS GO!! 🙌👏🤞🐂
0 · Reply
LVRTSSK
LVRTSSK Jun. 6 at 2:38 PM
$RDGL Maybe the guy who posts on Investors Hub (SC8) is right and RDGL is a scam and the Dr. is a moron when it comes to business. This FDA approval process has been a joke if RDGL is for real!
2 · Reply
bud63
bud63 Jun. 6 at 1:06 AM
$RDGL I feel like the only guy in the room that did not get the joke ,earlier I commented on a post about EFS I thought it was just a speculation of one’s opinion that Vivos might do that ,while on another site I read were they actually applied for it.This might be the beginning of break through .
1 · Reply
Doccjc62
Doccjc62 Jun. 5 at 9:20 PM
$RDGL Today's buy/sell volume,,,Buy: 950,873. Neutral: 9,066. Sell: 428,304
0 · Reply
UWB67
UWB67 Jun. 5 at 3:30 PM
$RDGL Naysayers aka DUMMIES are LYING and TRYING to take away from the Vivos EFS IDE submission on 5 June 2026 by stating (lying) that Vivos chose another path by submitting an EFS IDE. Do your due dilligence: Vivos Inc. Files Early Feasibility IDE Application with FDA for Radiogel™GlobeNewswire | 09/20/2021 Vivos was always working on and submitting an EFS IDE to begin human trials in the US. Lying dummies. EFS IDE APPROVAL will be a HUGE milestone for Vivos. DCGI (India) APPROVAL to conduct tests in humans towards commercialization in India will be a HUGE milestone for Vivos. GO VIVOS GO!! 🤞👏🙌👏🤞
1 · Reply
Dumbdumb4ever
Dumbdumb4ever Jun. 5 at 2:55 PM
$RDGL imo they went EFS route because it’s quicker, easier and cheaper, in the hopes to attract larger investors to support the next chapter. If they can prove the proof of concept, they will unlock the next chapter. If approved and 90 day results are showcased appropriately, we will be looking at 0.5$ by early next year. This also takes in DCGI approval that is most likely pending them opening the facility and getting it approved in India.
4 · Reply
Den44
Den44 Jun. 5 at 2:18 PM
$RDGL it’s time !
0 · Reply